GoodRx compiled a list of the most expensive prescription drugs on the market in 2017.
List prices represent costs for a 30-day supply for the most commonly prescribed dose, form and quantity of the drug as of January 2017, according to GoodRx. Prices do not account for insurance or discounts.
1. Harvoni
Cost: $87,800
Drugmaker: Gilead Sciences
Prescribed for: Hepatitis C
2. Sovaldi
Cost: $73,800
Drugmaker: Gilead Sciences
Prescribed for: Hepatitis C
3. Epclusa
Cost: $73,300
Drugmaker: Gilead Sciences
Prescribed for: Hepatitis C
4. Zepatier
Cost: $52,600
Drugmaker: Merck
Prescribed for: Hepatitis C
5. Mytesi
Cost: $51,700
Drugmaker: Napo Pharmaceuticals
Prescribed for: Hereditary angioedema
6. Bexarotene
Cost: $49,800
Drugmaker: Multiple since a generic
Prescribed for: Skin lesions associated with certain types of T-cell lymphoma
7. Daklinza
Cost: $49,400
Drugmaker: Bristol-Myers Squibb
Prescribed for: Hepatitis C
8. Orkambi
Cost: $41,200
Drugmaker: Vertex Pharmaceuticals
Prescribed for: Cystic fibrosis
9. HP Acthar
Cost: $40,800
Drugmaker: Mallinckrodt Pharmaceuticals
Prescribed for: Multiple sclerosis and gout
10. Viekira Pak
Cost: $34,600
Drugmaker: AbbVie
Prescribed for: Hepatitis C
More articles on supply chain:
Urine tests cost Colorado Medicaid $1M per month in 2016
EpiPens may prove effective 4 years past expiration date, researcher says
Express Scripts launches new pharmacy discount program, Inside Rx